^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    raloxifene hydrochloride

    i
    Associations
    News

    Trials

    Company:
    Generic mfg.
    Drug class:
    Selective estrogen receptor modulator
    Related drugs:
    Associations
    News

    Trials

    Apply
    Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease (NCT00200174)
    Phase N/A
    Memorial Sloan Kettering Cancer Center
    Completed
    Last update posted :
    07/04/2023
    Initiation :
    07/01/1999
    Primary completion :
    07/01/2003
    Completion :
    08/01/2008
    PGR
    |
    exemestane • raloxifene hydrochloride
    Nutritional Supplements and Hormonal Manipulations for Breast Cancer Prevention (NCT00723398)
    Phase N/A
    Milton S. Hershey Medical Center
    Completed
    Last update posted :
    11/01/2018
    Initiation :
    03/01/2009
    Primary completion :
    04/01/2015
    Completion :
    04/01/2015
    IL6 • IGF1 • IGFBP3 • CRP
    |
    pitavastatin • raloxifene hydrochloride
    Exemestane and Raloxifene in Treating Postmenopausal Women With a History of Ductal Carcinoma in Situ, Stage I, Stage II, or Stage III Breast Cancer (NCT00004247)
    Phase 2
    Memorial Sloan-Kettering Cancer Center
    Completed
    Last update posted :
    12/23/2015
    Initiation :
    04/01/1999
    Primary completion :
    08/01/2008
    ER
    |
    ER positive • ER negative
    |
    exemestane • raloxifene hydrochloride